US Patent 7914789 HEMCM42 antibodies
Patent 7914789 was granted and assigned to Facet Biotech on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+446 characters)
Article
Patent abstract
The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07914789 HEMCM42 antibodies US Patent 7914789 HEMCM42 antibodies
Infobox
Patent Number
0791478900
Patent Number
791478900
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079147890
Date of Patent
March 29, 2011
0Patent Application Number
118010400
Date Filed
May 7, 2007
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079147890
Date of Patent
March 29, 2011
0Patent Application Number
118010400
Date Filed
May 7, 2007
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07914789 HEMCM42 antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07914789
Date of patent
March 29, 2011
Patent application number
11801040
Date Filed
May 7, 2007
Patent primary examiner
Find more entities like US Patent 7914789 HEMCM42 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
